GoingToMeet

IBC's 3rd Annual Oligonucleotide Therapeutics Discovery conference will provide you with creative discovery and preclinical approaches to accelerate new lead discovery and candidate selection of oligonucleotide drugs, and teach you how to improve the drug-like properties of your molecules using preclinical chemical modification strategies. It will explore the cellular barriers to siRNA delivery and discuss mechanisms and novel approaches of delivery for various classes of oligonucleotide molecules. A highlight session of the conference will feature new data from oligonucleotide projects currently in preclinical and clinical development with a focus on lessons learned and experiences to date.